SONN - long - catalyst - low floater

29 Şub

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

This is not a financial advice!

2 upcoming catalyst on 31st of March 2024 and 30rd of June.

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Shs. Float of 2.78M
Rel. Vol. of 12.13 today

Keep an eye on 2.6 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 1.3

TPs approx. 4.5 , 6.7, 10

Most info on the chart.

Trade carefully!

11 Mar

Not

hit 3.13